What to watch with Omega-3 Index and gut health?

The Omega-3 Index (percentage of EPA+DHA in red blood cell membranes) is a validated biomarker for cardiovascular risk, but its link to gut health is less established. Genetic variants in FADS1/2 (e.g., rs174546) affect the conversion of plant-based ALA to EPA/DHA – carriers of unfavorable variants may have low Omega-3 Index despite high ALA intake. Gut microbiota can influence omega-3 absorption (e.g., via bile acid metabolism) and are themselves modulated by omega-3 supplementation (increase in butyrate-producing bacteria). However, evidence for direct clinical utility in gut health is limited: the Omega-3 Index alone does not indicate gut permeability, inflammation, or dysbiosis. MyBody-X tests provide the index and FADS genotype, but interpretation should be conservative. High omega-3 doses (>3 g/day) may cause gastrointestinal side effects (nausea, diarrhea). Caution against overinterpretation: a low index does not automatically imply impaired gut function, and improving the index via supplements does not cure gut diseases. Combining genetics, diet, and microbiome analysis may offer clues but does not replace medical diagnosis.